Ambalal Sarabhai Enterprises
AMBALALSANSE

Ambalal Sarabhai Enterprises

₹30.960.05 (0.16%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
30.67
Today’s high
31.80
52 week low
30.30
52 week high
36.15
Open price
31.80
Previous close
30.91
Live volume
21,786
Lower circuit
24.73
Upper circuit
37.09

Fundamentals

Market Cap
₹237Cr
ROE
10.60%
P/E Ratio(TTM)
21.51
EPS(TTM)
1.44
P/B Ratio
1.61
Dividend Yield
0.00%
Industry P/E
34.42
Book Value
19.25
Debt to Equity
0.32
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹54.58
+18.47%
Profit (Cr)
₹3.64
+750.00%
-200255075
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+6%
3Y CAGR-5%
Profit growthValue
1Y (TTM)+63%
3Y CAGR-53%

About

Ambalal Sarabhai Enterprises Limited is a diversified company with core operations in the pharmaceuticals and electronics manufacturing sectors, supported by its subsidiaries and joint ventures. Its focused subsidiaries have recorded significant progress in key areas including Active Pharmaceutical Ingredients manufacturing, Molecular Diagnostics, and niche Effervescent products. The group maintains a clear emphasis on disease-based solutions, leveraging its robust technological capabilities to drive future growth in both healthcare and electronics. Its joint venture, Vovantis, operates a USFDA-approved manufacturing plant in Ranoli, with an increased focus on products for the USA and European markets. Another key subsidiary, Synbiotics, is a USFDA inspected company that manufactures an antifungal active ingredient, Amphotericin B, for an expanding global market. Furthermore, its Asence subsidiary specializes in supplying quality pharmaceutical preparations to international markets, with over 100 products registered worldwide.;
CEO/MD
Mr. Mohal K. Sarabhai
Founded in
1977
NSE symbol
AMBALALSA

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
68.64%
Promoters
31.36%
Other Domestic Institutions
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹874.90
+3.05 (0.35%)
L
    H
    4,968.5535.254.55
    ₹377.50
    +15.20 (4.20%)
    L
      H
      3,946.1882.4914.92
      ₹404.05
      +2.05 (0.51%)
      L
        H
        3,756.3841.915.15
        Orchid PharmaORCHPHARMA
        ₹695.55
        -13.10 (1.85%)
        L
          H
          3,589.90190.272.82
          2026
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks